Stephen Boppart
· ProfessorVerifiedUniversity of Illinois Urbana-Champaign · Bioengineering
Active 1992–2026
About
Stephen Boppart is a Professor and Grainger Distinguished Chair in Engineering at the University of Illinois Urbana-Champaign (UIUC), with appointments in the Departments of Electrical and Computer Engineering, Bioengineering, the Carle Illinois College of Medicine, and the Beckman Institute for Advanced Science and Technology. His Biophotonics Imaging Laboratory focuses on developing novel optical biomedical diagnostic and imaging technologies and translating these into clinical applications. His primary research areas include biomedical imaging, biophotonics, image-guided surgery, intravital microscopy, lasers in medicine and biology, Optical Coherence Tomography (OCT), optical diagnostics for cancer, point-of-care diagnostics, and primary care imaging. Prof. Boppart received his Ph.D. in Medical and Electrical Engineering from MIT and his M.D. from Harvard Medical School, with specialty training in Internal Medicine. He has published over 475 publications, delivered more than 1000 presentations, and holds over 55 patents related to optical biomedical imaging technology. Recognized as one of the Top 100 Young Innovators by MIT Technology Review, he has received numerous awards including the Paul F. Forman Engineering Excellence Award, the Hans Sigrist Prize, the IEEE Technical Achievement Award, and the SPIE Biophotonics Technology Innovator Award. He has co-founded four start-up companies to commercialize his optical technologies and is a member of the National Academy of Inventors. His leadership roles include directing the NIH/NIBIB P41 Center for Label-free Imaging and Multiscale Biophotonics (CLIMB), serving as Director of the GSK Center for Optical Molecular Imaging, and acting as Interim Director of the Interdisciplinary Health Sciences Institute at UIUC. He has been actively involved in initiatives to integrate engineering, technology, and medicine to advance human health and healthcare systems, including his role in the development of the Carle Illinois College of Medicine and his current position as Illinois Co-Chair of the Mayo Clinic & Illinois Alliance for Technology-Based Healthcare.
Research topics
- Medicine
- Internal medicine
- Computer Science
- Biology
- Oncology
- Cancer research
- Biochemistry
- Emergency medicine
- Medical emergency
- Simulation
- Chemistry
- Endocrinology
- Anesthesia
- Immunology
Selected publications
IEEE Journal of Selected Topics in Quantum Electronics · 2026-01-05
articleOpen accessSenior authorNonlinear microscopy enables label-free imaging by deriving contrast from the intrinsic spectroscopic responses of specimens, thereby offering a valuable tool for biomedical applications. Often, clinical imaging systems implement either multiphoton or vibrational contrast, not both. Consequently, most clinically deployed label-free nonlinear microscopes lack a robust, complementary contrast palette suitable for investigating the morphofunctional features of heterogeneous specimens. This deficiency limits not only the analytical capabilities of the nonlinear microscope but also its diagnostic utility. A main reason for this disregard is that the various imaging modalities impose distinct and stringent requirements on the excitation source and the detection chain. In this contribution, we propose a strategy that targets both multiphoton and vibrational contrasts to achieve a robust, complementary contrast palette. The approach emerges from a systematic investigation of readout schemes and provides engineering criteria to tailor the detection chain and thus maximize quantitative performance. In concert with this detection strategy, we present a compact laser source that drives vibrational coherences while simultaneously exciting multiphoton signals. We validate the resulting imaging platform using two rodent case studies: one involving a naturally occurring metastatic cancer in a mouse and another relying on an allogeneic mammary cancer model in a rat. Owing to its dimensions, cost, and versatility, we anticipate that this biophotonics tool will readily find its way into clinical applications.
2026-03-05
articleSenior author2026-03-05
articleSenior author2026-03-05
article2026-03-05
articleSenior authorEnabling digital histopathology through long-wavelength NIR CARS microscopy
2026-03-05
articleSenior authorSurface versus Nanocatalyst-Induced Matrix Bubbles Govern Temperature-Dependent Biofilm Removal
ACS Applied Materials & Interfaces · 2026-03-31
articleOpen accessBacterial biofilms protected by viscoelastic extracellular polymeric substances (EPS) are highly resistant to chemical disinfectants and rapidly regenerate after treatment. While bubble-mediated mechanical disruption has emerged as an eco-friendly antifouling strategy, bubbles generated by conventional tools act on biofilm surfaces and fail to disrupt three-dimensional biofilms. Here, we demonstrate that generating bubbles within biofilms, referred to as matrix bubbles, and controlling their dynamics with temperature, enables effective matrix disruption and biofilm removal. Using P. aeruginosa biofilms as a model system, we compared H2O2 alone with MnO2 nanocatalyst-doped biosilica microparticles (MnO2-biosilica) across a range of temperatures. H2O2 alone produced catalase-driven O2 bubbles localized on the biofilm surface with minimal temperature dependence, resulting in limited biofilm removal. In contrast, MnO2-biosilica generated temperature-amplified matrix bubbles that formed swarms, penetrated biofilms, disrupted EPS, and suppressed regrowth at elevated temperatures (25 and 40 °C). Kinetic and imaging analyses revealed that this temperature-dependent behavior arises from accelerated MnO2-catalyzed H2O2 decomposition coupled with enhanced bubble expansion and rupture, which deliver strong mechanical perturbation within the biofilm matrix. Importantly, nanocatalyst-induced matrix bubbles effectively removed biofilm from complex surgical instrument geometries and acted synergistically with autoclaving. This study therefore establishes temperature-controlled, nanocatalyst-mediated matrix bubble dynamics as a physical strategy for overcoming biofilm resistance in clinical and industrial settings.
2026-03-05
articleSenior author2026-03-05
article1st authorCorrespondingParticle sizing and resolution enhancement in nonlinear microscopy imaging of extracellular vesicles
2026-03-05
articleSenior author
Recent grants
NIH · $330k · 2009
NIH · $2.2M · 2017
NIH · $1.6M · 2019–2023
Fiber-Delivered Programmable Supercontinuum Laser Adaptive to EvolvingNeurophotonic Research
NIH · $878k · 2019–2022
NIH · $1.3M · 2014
Frequent coauthors
- 251 shared
Eric J. Chaney
University of Illinois Urbana-Champaign
- 234 shared
Mark E. Brezinski
Brigham and Women's Hospital
- 222 shared
Marina Marjanović
Singidunum University
- 206 shared
James G. Fujimoto
Massachusetts Institute of Technology
- 195 shared
Costas Pitris
University of Cyprus
- 142 shared
Haohua Tu
- 138 shared
Darold R. Spillman
University of Illinois Urbana-Champaign
- 105 shared
Brett E. Bouma
Labs
Prof. Boppart's LabPI
Education
- 1992
Ph.D., Bioengineering
University of Illinois at Urbana-Champaign
- 1988
M.S., Bioengineering
University of Illinois at Urbana-Champaign
- 1985
B.S., Engineering Physics
University of Illinois at Urbana-Champaign
Awards & honors
- Paul F. Forman Engineering Excellence Award from Optica
- Hans Sigrist Prize in the field of Diagnostic Laser Medicine
- IEEE Technical Achievement Award
- SPIE Biophotonics Technology Innovator Award
- Top 100 Young Innovators by MIT Technology Review magazine
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Stephen Boppart
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup